TUBA1C and cancer: In addition, we explored the association between TUBA1C expression and the DFI in patients with different cancer types and found that increased TUBA1C expression was correlated with a decreased DFI in LGG (p < 0.001, HR = 3.229), LUAD (p = 0.007, HR = 1.445), PAAD (p = 0.005, HR = 2.281) and SARC (p = 0.026, HR = 1.314) (Fig. 5A).